UPDATE | July 26, 2021

Achieving Accelerated Tech Transfer for a COVID-19 Program: Development to Manufacturing

  • MAIL

Achieving_accelerated_tech_transfer_for_a_COVID-19_program-_Development_to_manufacturing.png

Technology transfer is a critical step along the path to the large-scale production of COVID-19 therapeutics, but its highly complex nature makes it time-consuming. In this whitepaper, Andrew Kim, our Associate Director of Downstream MSAT, explains how accelerating tech transfer without sacrificing quality demands strong communication, operational agility, early investment in critical path items, and continuous risk management. As a trusted CDMO partner, Samsung Biologics has successfully accelerated tech transfer down to three to five months for clients developing COVID-19 therapies.

Achieving_accelerated_tech_transfer_for_a_COVID-19_program-_Development_to_manufacturing.png

Technology transfer is a critical step along the path to the large-scale production of COVID-19 therapeutics, but its highly complex nature makes it time-consuming. In this whitepaper, Andrew Kim, our Associate Director of Downstream MSAT, explains how accelerating tech transfer without sacrificing quality demands strong communication, operational agility, early investment in critical path items, and continuous risk management. As a trusted CDMO partner, Samsung Biologics has successfully accelerated tech transfer down to three to five months for clients developing COVID-19 therapies. 

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required